Electromyographic Assessment of Sleep Bruxism in Patients With Stage III and IV Periodontitis
1 other identifier
observational
40
1 country
1
Brief Summary
This study aims to investigate the association between periodontitis Stage III and IV and the intensity and duration of sleep bruxism episodes. Surface electromyography (EMG) of the masseter muscle will be used to instrumentally assess sleep bruxism in patients with and without periodontal disease
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2025
CompletedStudy Start
First participant enrolled
June 27, 2025
CompletedFirst Posted
Study publicly available on registry
July 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2025
CompletedSeptember 4, 2025
September 1, 2025
1 month
June 27, 2025
September 3, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Sleep Bruxism Work Index (BWI)
BWI is calculated as the percentage of muscle work exerted during bruxism-related masticatory activity relative to the theoretical maximum work. It will be used to assess the intensity of sleep bruxism based on EMG recordings of the masseter muscle
Within 24 hours after EMG device application
Study Arms (2)
Periodontitis Group
Patients diagnosed with Stage III or IV periodontitis according to the 2017 World Workshop classification. Participants will undergo full-mouth periodontal examination and 24-hour surface EMG recording of the masseter muscle to assess sleep bruxism activity.
Healthy Control Group
Participants without clinical signs of periodontal disease, matched by age and sex to the periodontitis group. They will also receive a full-mouth periodontal screening and 24-hour surface EMG recording of the masseter muscle for sleep bruxism assessment.
Interventions
Participants will undergo 24-hour surface electromyographic recording of the left masseter muscle using the dia-BRUXO portable device to quantify sleep bruxism activity through Bruxism Work Index (BWI) and Bruxism Time Index (BTI).
Eligibility Criteria
Adult patients and healthy controls aged 28-50 years recruited at the University of Siena, Italy. The study includes both individuals with advanced periodontitis and healthy controls.
You may qualify if:
- Age between 28 and 50 years
- Ability to perform adequate oral hygiene
- Willingness to participate and sign informed consent
- For periodontitis group: Diagnosis of Stage III or IV periodontitis
- For control group: Absence of periodontal disease
You may not qualify if:
- Use of removable dentures
- Ongoing orthodontic treatment
- Temporomandibular disorders (TMD) or orofacial pain
- Use of medications affecting muscle activity
- Systemic or psychiatric disorders
- Diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AOUS
Siena, 53100, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nicola Discepoli, DDS, PhD
Department of Medical Biotechnologies, University of Siena
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
June 27, 2025
First Posted
July 8, 2025
Study Start
June 27, 2025
Primary Completion
July 31, 2025
Study Completion
July 31, 2025
Last Updated
September 4, 2025
Record last verified: 2025-09